# Zyla Life Sciences

Zyla Life Sciences is a company headquartered in Wayne, PA, United States.

## Company overview

- **Legal name:** Zyla Life Sciences
- **Former names in filing history:** Egalet Corp (2013-09-17 to 2019-05-20)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Wayne, PA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001586105

## About

Zyla Life Sciences is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001586105, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-03-29, it reported annual revenue of USD 30,353,000; total assets of USD 61,933,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $30.4M (USD 30,353,000)
- **Total assets:** $61.9M (USD 61,933,000)
- **Cash and equivalents:** $35.3M (USD 35,323,000)
- **Operating cash flow:** -$54.8M (USD -54,814,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $26.1M (USD 26,136,000)
- **Total assets:** $119.9M (USD 119,858,000)
- **Cash and equivalents:** $31.1M (USD 31,090,000)
- **Operating cash flow:** -$65.2M (USD -65,164,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $17.0M (USD 16,964,000)
- **Total assets:** $114.9M (USD 114,858,000)
- **Cash and equivalents:** $44.4M (USD 44,355,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $22.8M (USD 22,830,000)
- **Total assets:** $172.4M (USD 172,416,000)
- **Cash and equivalents:** $46.7M (USD 46,665,000)

## Recent SEC filings

- Form 8-K — filed 2020-05-20 — period 2020-05-20 — FORM 8-K
- Form 8-K — filed 2020-05-20 — period 2020-05-19 — FORM 8-K
- Form 8-K — filed 2020-05-15 — period 2020-05-15 — FORM 8-K
- Form 8-K — filed 2020-05-15 — period 2020-05-15 — FORM 8-K
- Form 10-Q — filed 2020-05-14 — period 2020-03-31 — 10-Q
- Form 10-K/A — filed 2020-04-28 — period 2019-12-31 — 10-K/A
- Form DEF 14A — filed 2020-04-20 — period 2020-05-19 — DEF 14A
- Form 8-K — filed 2020-04-13 — period 2020-04-13 — FORM 8-K
- Form 8-K — filed 2020-03-27 — period 2020-03-27 — FORM 8-K
- Form 10-K — filed 2020-03-26 — period 2019-12-31 — 10-K
- Form SC 13D — filed 2020-03-26 — SC 13D
- Form 8-K — filed 2020-03-17 — period 2020-03-16 — FORM 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/zyla-life-sciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology
